Age-related differences in susceptibility to carcinogenesis: A quantitative analysis of empirical animal bioassay data

Environmental Health Perspectives

Volumn 112, Issue 11, 2004, Pages 1152-1158

  Hattis, Dale ^a   Goble, Robert ^a   Russ, Abel ^a   Chu, Margaret ^b   Ericson, Jen ^a  

^a CLARK UNIVERSITY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Carcinogenesis; Fetal; Ionizing radiation; Mutagenic chemicals; Risk assessment; Statistical analysis; Susceptibility

Indexed keywords

CARCINOGEN; MUTAGENIC AGENT; NITROSOUREA DERIVATIVE;

AGING; AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BIRTH; BODY WEIGHT; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DATA ANALYSIS; ENVIRONMENTAL PROTECTION; FEMALE; FETUS; FETUS DEVELOPMENT; FOOD; HEALTH CARE INDUSTRY; IONIZING RADIATION; LACTATION; MALE; METABOLISM; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION EXPOSURE; RAT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STATISTICAL ANALYSIS; UNITED STATES; WEANING;

ANIMALIA;

EID: 4344679454     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6871     Document Type: Article

References (35)

1. Basu TK, Dickerson JWT, Parke DVW. 1971. Effect of development on the activity of microsomal drug-metabolizing enzymes in rat liver. Biochem J 124:19-24.
2. Boxenbaum H. 1982. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 10(2):201-227.
3. Cahill DF, Wright JF, Godbold JH, Ward JM, Laskey JW, Tompkins EA. 1975. Neoplastic and life-span effects of chronic exposure to tritium. II. Rats exposed in utero. J Natl Cancer Inst 55:1165-1169.
4. Castanera TJ, Jones DC, Kimeldorf DJ, Rosen VJ. 1971. The effect of age at exposure to a sublethal dose of fast neutrons on tumorigenesis in the male rat. Cancer Res 31:1543-1549.
5. Di Majo V, Coppola M, Rebessi S, Covelli V. 1990. Age-related susceptibility of mouse liver to induction of tumors by neutrons. Radiat Res 124:227-234.
6. 3/4/day. Fed Reg 57:24152-24173.
7. Fialkow PJ. 1977. Clonal origin and stem cell evolution of human tumors. In: Genetics of Human Cancer (Mulvihill JJ, Miller RW, Fraumeni JF, eds). New York:Raven Press, 439-452.
8. Ginsberg G, Hattis D, Sonawane B, Russ A, Banati P, Kozlak M, et al. 2002. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol Sci 66:185-200.
9. Haas CN. 1994. Dose response analysis using spreadsheets. Risk Anal 14:1097-1100.
10. Hattis D. 2004. Human Interindividual Variability Homepage. Available: http://www2.clarku.edu/faculty/dhattis [accessed 15 June 2004].
11. Hattis D, Anderson E. 1999. What should be the implications of uncertainty, variability, and inherent "biases"/" conservatism" for risk management decision making? Risk Anal 19:95-107.
12. Hattis D, Burmaster DE. 1994. Assessment of variability and uncertainty distributions for practical risk analyses. Risk Anal 14:713-730.
13. Hattis D, Ginsberg G, Sonawane B, Smolenski S, Russ A, Kozlak M, et al. 2003. Differences in pharmacokinetics between children and adults - II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal 23:117-142.
14. Knowles JF. 1985. Changing sensitivity of neonatal rats to tumorigenic effects of N-nitroso-N-ethylurea and X-radiation, given singly or combined. J Natl Cancer Inst 74:853-857.
15. Knudson AG. 1973. Mutation and human cancer. Adv Cancer Res 17:317-352.
16. Knudson AG. 1977. Genetics and etiology of human cancer. Adv Hum Genet 8:1-66.
17. MacLeod SM, Renton KW, Eade NR. 1972. Development of hepatic microsomal drug-oxidizing enzymes in immature male and female rats. J Pharmacol Exp Ther 183:489-498.
18. Maltoni C, Lefemine G, Ciliberti A, Cotti G, Carretti D. 1984. Experimental research on vinyl chloride carcinogenesis. In: Archives of Research on Industrial Carcinogenesis, Vol 2 (Maltoni C, Mehlman MA, eds). Princeton, NJ:Princeton Scientific Publishers, 1-533.
19. McCullagh P, Nelder JA. 1989. General Linear Models. 2nd ed. London:Chapman and Hall.
20. National Research Council. 2002. Estimating the Public Health Benefits of Proposed Air Pollution Regulations. Washington, DC:National Academy Press.
21. Nomura T. 1976. Comparison of tumour susceptibility among various organs of foetal, young and adult ICR/Jcl mice. Br J Cancer 33:521-533.
22. 1 Mice (Inhalation Studies). TR-434. Research Triangle Park, NC:National Toxicology Program.
23. NTP. 1999. Toxicology and Carcinogenesis Studies of Pentachlorophenol (CAS No. 87-86-5) in F344/N Rats (Feed Studies). TR-483. Research Triangle Park, NC:National Toxicology Program.
24. OMB. 2000. Guidelines to Standardize Measures of Costs and Benefits and the Format of Accounting Statements. Memorandum from Jacob J. Lew, 22 March 2000. Washington, DC:Office of Management and Budget. Available: http://www.whitehouse.gov/omb/memoranda/m00-08.pdf [accessed 11 May 2004].
25. Peto R, Gray R, Brantom P, Grasso P. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3, 6 or 20 weeks) and of species (rats, mice, or hamsters). IARC Sci Publ 57:627-665.
26. Peto R, Gray R, Brantom P, Grasso P. 1991. Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res 51:6415-6451.
27. Sasaki S. 1991. Influence of the age of mice at exposure to radiation on life-shortening and carcinogenesis. J Radiat Res 32(suppl 2):73-85.
28. Terracini B, Testa MC, Cabral JB, Rossi L. 1976. The roles of age at treatment and dose in carcinogenesis in C3HfDp mice with a single administration of N-nitroso-N-methylurea. Br J Cancer 33:427-439.
29. Travis CC, White RK. 1988. Interspecific scaling of toxicity data. Risk Anal 8:119-125.
30. Travis CC, White RK, Ward RC. 1990. Interspecies extrapolation of pharmacokinetics. J Theor Biol 142:285-304.
31. U.S. EPA. 2001. Risk Assessment Guidance for Superfund. Vol III, Part A. Process for Conducting Probabilistic Risk Assessment. EPA/540-R-02-002. Washington, DC:U.S. Environmental Protection Agency.
32. U.S. EPA. 2003a. Draft Final Guidelines for Carcinogen Risk Assessment (External Review Draft). Washington, DC:U.S. Environmental Protection Agency, Risk Assessment Forum. Available: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=55445 [accessed 15 June 2004).
33. U.S. EPA. 2003b. Supplemental Guidance for Assessing Cancer Susceptibility from Early-Life Exposure to Carcinogens (External Review Draft). Washington, DC:U.S. Environmental Protection Agency, Risk Assessment Forum. Available: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=55446 [accessed 11 May 2004].
34. Venzon DJ, Moolgavkar SH. 1988. A method for computing profile-likelihood-based confidence intervals. Appl Stat 37:87-94.
35. Zhang S, Leske DA, Lanier WL, Holmes JM. 2001. Postnatal growth retardation exacerbates acidosis-induced retinopathy in the neonatal rat. Curr Eye Res 22(2):133-139.